Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-01-17FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for HYZAAR, a fixed-dose combination of losartan potassium and hydrochlorothiazide, submitted by…
-
FDA approval · 2014-01-17FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for the Spironolactone and Hydrochlorothiazide combination product (Prasco Laboratories), indica…
-
FDA approval · 2014-01-08FDA Approved: TELMISARTAN AND AMLODIPINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' telmisartan and amlodipine fixed-dose combination under an Original ANDA (ANDA201586).
-
FDA approval · 2014-01-08FDA Approved: TELMISARTAN — Original Application (Chartwell RX, LLC.)
The FDA approved Chartwell RX, LLC.'s original application for a generic telmisartan, expanding access to treatment for hypertension.
-
FDA approval · 2014-01-03FDA Approved: FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic combination product fosinopril sodium and hydrochlorothiazide. The product is manufact…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-12-31FDA Approved: FOSINOPRIL SODIUM — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for fosinopril sodium from Chartwell RX, LLC, indicating approval of an ANDA supplemental submission…
-
FDA approval · 2013-12-31FDA Approved: FOSINOPRIL SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for fosinopril sodium from Aurobindo Pharma Limited.
-
FDA approval · 2013-12-30FDA Approved: AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved the original application for a generic amlodipine and benazepril hydrochloride tablet from Heritage Pharmaceuticals (Avet) for …
-
FDA approval · 2013-12-12FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for the combination drug Bisoprolol Fumarate and Hydrochlorothiazide (Teva) to modify/expand its lab…
-
FDA approval · 2013-11-29FDA Approved: AMLODIPINE AND ATORVASTATIN — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves an original ANDA for AMLODIPINE AND ATORVASTATIN (Mylan Pharmaceuticals Inc.), a generic fixed-dose combination product.
-
FDA approval · 2013-11-19FDA Approved: INNOPRAN XL — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' supplemental application for INNOPRAN XL (propranolol hydrochloride). The approval confirms changes to the…
-
FDA approval · 2013-11-08FDA Approved: CLEVIPREX — Supplemental Application (Fresenius Kabi Austria GmbH)
The FDA approved a supplemental application for CLEVIPREX (clevidipine), submitted by Fresenius Kabi Austria GmbH. The action is categorized…
-
FDA approval · 2013-11-08FDA Approved: FELODIPINE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a generic felodipine under an Abbreviated New Drug Application by Heritage Pharmaceuticals (Avet) to treat hypertension and ang…
-
FDA approval · 2013-11-07FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for amlodipine and atorvastatin (amlodipine besylate and atorvastatin calci…
-
FDA approval · 2013-11-06FDA Approved: DOXAZOSIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for doxazosin by Mylan Pharmaceuticals Inc., indicating approval of the supplemental request.
-
FDA approval · 2013-11-06FDA Approved: METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved a generic combination product of metoprolol tartrate and hydrochlorothiazide for the treatment of hypertension.
-
FDA approval · 2013-11-04FDA Approved: ALISKIREN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Aliskiren hemifumarate submitted by Prasco Laboratories.
-
FDA approval · 2013-10-29FDA Approved: CLONIDINE — Original Application (XGen Pharmaceuticals DJB, Inc.)
FDA approved a generic clonidine product from XGen Pharmaceuticals DJB, Inc. under an Original ANDA submission.
-
FDA approval · 2013-10-29FDA Approved: LISINOPRIL — Original Application (Exelan Pharmaceuticals Inc.)
FDA approved Exelan Pharmaceuticals’ Original Application for lisinopril, a generic ACE inhibitor, marking the availability of a generic lis…
-
FDA approval · 2013-10-18FDA Approved: DIOVAN — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Diovan (valsartan) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2013-09-12FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Norvasc (amlodipine besylate) submitted by Viatris Specialty LLC.
-
FDA approval · 2013-09-10FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved Actavis's supplemental application for a generic lisinopril and hydrochlorothiazide tablet, expanding the approval to inclu…
-
FDA approval · 2013-08-30FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approves Teva Pharmaceuticals’ supplemental application for amlodipine besylate (generic) under ANDA076846. This action represents an ap…
-
FDA approval · 2013-08-30FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for amlodipine besylate from Epic Pharma, enabling the generic product to be marketed.
-
FDA approval · 2013-08-29FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for the irbesartan and hydrochlorothiazide combination from Alembic Pharmaceuticals Limited, authori…